GlaxoSmithKline (Jobs) ‘s Cervarix Priced on Par with Merck & Co., Inc. (Jobs) ‘s Gardasil in UK

LONDON, Oct 2 (Reuters) - GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) launched its cervical cancer vaccine Cervarix in Britain on Tuesday, pricing it at the same level as Merck & Co’s (MRK.N: Quote, Profile, Research) rival Gardasil.